Practice Pearls for the Management of Atopic Dermatitis
Alexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.
Read More
Future Directions for the Management of Atopic Dermatitis
Experts in dermatology hypothesize about the next round of treatment disruptions and their hopes for the future of atopic dermatitis management.
Emerging Therapies for Pediatric Atopic Dermatitis Management
Alexa Hetzel, MA, PA-C, and Lakshi Aldredge, MSN, ANP-BC, DCNP, provide insight into emerging therapies and ongoing investigations in the management of pediatric atopic dermatitis.
Impact of Treatment Response Time on Pediatric Atopic Dermatitis Burden
Experts in dermatology comment on the impact of treatment response time on pediatric atopic dermatitis burden.
Real-World Experience With Dupilumab
Alexa Hetzel, MA, PA-C; Matthew Brunner, PA; and Lakshi Aldredge, MSN, ANP-BC, DCNP, share their real-world utilization experiences with dupilumab in pediatric patients with atopic dermatitis.
Evolution of Pediatric Atopic Dermatitis Treatment Landscape
Lakshi Aldredge, MSN, ANP-BC, DCNP, reviews the evolution of the treatment landscape for pediatric patients with atopic dermatitis; highlighting recent advances.
Considerations and Challenges With Topical Therapies for Pediatric Patients With Atopic Dermatitis
A panel of experts in dermatology share their tips and tricks when utilizing topical therapies for pediatric patients with atopic dermatitis.
Patient-Centered Approach for Atopic Dermatitis Care
Matthew Brunner, PA, shares his advice for engaging pediatric patients with atopic dermatitis in their treatment and disease care, while Lakshi Aldredge, MSN, ANP-BC, DCNP, discusses her treatment protocols.
Multidisciplinary Management in Pediatric Atopic Dermatitis
A panel of experts in dermatology management provide insight into the role of multidisciplinary care for pediatric patients with atopic dermatitis.
Pediatric Atopic Dermatitis: Clinical Examination
Melodie Young, NP; Alexa Hetzel, MA, PA-C; and Matthew Brunner, PA, discuss their approach to a clinical examination of patients with pediatric atopic dermatitis.
Pediatric Atopic Dermatitis: Clinical Presentation
Experts in dermatology describe their clinical experiences of atopic dermatitis presentation in their patients, focusing on the heterogeneity across age groups and races.
Atopic Dermatitis Disease Prevalence by Age
Lakshi Aldredge, MSN, ANP-BC, DCNP, provides an overview of the prevalence of atopic dermatitis across age groups and discusses the impact of itch on these patients.
Pediatric Atopic Dermatitis: Prevalence and Symptomology
Melodie Young, NP; Alexa Hetzel, MA, PA-C; and Matthew Brunner, PA, provide insight into pediatric atopic dermatitis, highlighting disease recurrence and symptomology.
Anticipated Developments in the Field of Plaque Psoriasis
Matthew Brunner, MHS, PA-C, DFAAPA, highlights the most anticipated developments in the field of treating patients with plaque psoriasis.
Stratifying Patients With Plaque Psoriasis for Treatment With Biologics
Stratification of patients for the treatment of plaque psoriasis based on comorbidities and prior biologic experience.
Switching Therapies for Plaque Psoriasis
Advanced practice providers discuss scenarios in which they would consider switching between therapies when treating patients with plaque psoriasis.
Provider Experience With Using IL-23 Inhibitors to Treat Plaque Psoriasis
Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, MHS, PA-C, DFAAPA share their personal experiences with using IL-23 inhibitors in treating patients with plaque psoriasis.
IL-23 Inhibitors in the Treatment of Plaque Psoriasis
Mechanism of action and dosing of IL-23 inhibitors use to treat plaque psoriasis as explained by advanced practice providers.
Interleukin Inhibitors to Treat Plaque Psoriasis
IL-17 inhibitors and IL-12/23 inhibitors used in the treatment of plaque psoriasis.
TNF Inhibitors in the Management of Plaque Psoriasis
Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, share their experiences with tumor necrosis factor (TNF) inhibitors in treating plaque psoriasis.
Plaque Psoriasis: Transition From Topical to Oral Therapy
Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, discuss factors leading to transition from topical agents to oral systemic therapies for plaque psoriasis.
Nonbiologic Oral Systemics for Plaque Psoriasis
Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, review use of nonbiologic oral systemic agents (eg, apremilast, methotrexate, acitretin) in the management of plaque psoriasis.
Current Role of Topical Therapy in Plaque Psoriasis
Matthew Brunner, MHS, PA-C, DFAAPA, and Lakshi Aldredge, MSN, ANP-BC, DCNP, discuss the current role of topical medications as the standard of care for initial therapy in plaque psoriasis.
Factors That Trigger Flare-ups in Plaque Psoriasis
Lifestyle modification and counseling to help manage flare-ups resulting from triggers for plaque psoriasis.
Diagnosing and Treating Patients With Plaque Psoriasis
Diagnosis and management of plaque psoriasis as discussed by advanced practice providers.
Plaque Psoriasis: Assessing Disease Severity
Advanced practice providers share their perspectives on assessing and grading the disease severity of plaque psoriasis.
Impact of Psoriasis on a Patients’ Overall Well-Being
The clinical and psychological impact of plaque psoriasis on a patient’s overall well-being.